Working... Menu
Trial record 4 of 11 for:    Cavernous Malformation

Treat_CCM: Propranolol in Cerebral Cavernous Malformation (Treat_CCM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03589014
Recruitment Status : Recruiting
First Posted : July 17, 2018
Last Update Posted : May 2, 2019
IFOM, The FIRC Institute of Molecular Oncology
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 31, 2020
  Estimated Study Completion Date : December 31, 2020